Idarubicinol
CAS: 86189-66-4
Rif. 3D-LDA18966
| 5mg | Prezzo su richiesta | ||
| 10mg | Prezzo su richiesta | ||
| 25mg | Prezzo su richiesta | ||
| 50mg | Prezzo su richiesta |
Informazioni sul prodotto
- 5,12-Naphthacenedione, 7-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-(1-hydroxyethyl)-, [7S-[7α,9α,9(R*)]]-
- 5,12-Naphthacenedione, 7-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-[(1S)-1-hydroxyethyl]-, (7S,9S)-
- 4-Demethoxydaunorubicinol
- (7S,9S)-7-[(3-Amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-[(1S)-1-hydroxyethyl]-5,12-naphthacenedione
- Antibiotic FCE 22723
Idarubicinol is an analog of the anticancer drug idarubicin and is known for its potent apoptotic effects on cancer cells. It works by inhibiting protein kinases, which are enzymes that play a crucial role in cancer cell growth and division. Idarubicinol has been shown to be effective against a wide range of human cancers, including Chinese hamster ovary (CHO) tumors. This medicinal compound has been identified in urine samples from patients undergoing chemotherapy with idarubicin, indicating that it may play a role in the treatment of cancer. As an inhibitor of kinases, Idarubicinol has potential as a therapeutic agent for the treatment of various types of cancer.
Proprietà chimiche
Richiesta tecnica su: 3D-LDA18966 Idarubicinol
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
